| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Medical Equipment/Supplies/Accessories
|
Compare with Industry peers |
| Website | http://www.centenialindia.com | |
| Market Cap | 18.95 Cr. | |
| Enterprise Value(EV) | 27.99 Cr. | 2022-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.72 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 30.22 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 44.77 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 77.91 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 0.67 | Calculated using Price: 51.95 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.36 Cr. | 3,648,300 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Centenial Surgical Suture Ltd., founded in 1995, manufactures a broad range of quality sterile needled sutures, with state-of-the-art manufacturing and packaging equipment, sophisticated processes designed and operated by Centenial's competent and devoted staff. Centenial Sutures is a combination of Craftmanship, the Latest Production Technology, Strictest Quality Control, Care and Dedication, results in Products of Incomparable Quality. Centenial is a company with a Surgeon's eye for Quality. At Centenial doing business the fair way is their Foremost Concern, by Guaranteeing Courteous, Fair and Honest Service, enough inventory to meet any order size and pricing. Centenial is confident that it can prove its flexibility, capacity and attention for Quality and Consistency in manufacturing world class sutures in India. | ||
| 1 Day |
|
-4.94% |
| 1 Week |
|
-5.46% |
| 1 Month |
|
+0.58% |
| 3 Month |
|
-6.14% |
| 6 Month |
|
-20.20% |
| 1 Year |
|
+1.96% |
| 2 Year |
|
+34.41% |
| 5 Year |
|
-14.70% |
| 10 Year |
|
+100.97% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 10.80 | 10.37 | 7.72 | 7.86 | 6.56 | 7.98 | 4.88 | 3.52 | 2.23 | |
| Return on Capital Employed (%) | 13.36 | 14.22 | 11.74 | 14.02 | 14.84 | 16.75 | 12.64 | 8.65 | 7.27 | |
| Return on Assets (%) | 3.66 | 3.64 | 2.89 | 3.17 | 2.77 | 3.60 | 2.06 | 1.38 | 0.95 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Shh. Funds | 17 | 19 | 21 | 23 | 25 | 26 | 28 | 29 | 30 | 30 | |
| Non Curr. Liab. | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 10 | 9 | 7 | |
| Curr. Liab. | 26 | 27 | 31 | 27 | 28 | 26 | 26 | 31 | 32 | 24 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 48 | 50 | 55 | 53 | 56 | 55 | 57 | 69 | 70 | 61 | |
| Non Curr. Assets | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 11 | 9 | 8 | |
| Curr. Assets | 43 | 45 | 51 | 49 | 52 | 51 | 52 | 58 | 61 | 53 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 48 | 50 | 55 | 53 | 56 | 55 | 57 | 69 | 70 | 61 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 54 | 51 | 52 | 51 | 53 | 53 | 56 | 56 | 37 | 44 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 54 | 51 | 52 | 51 | 53 | 53 | 56 | 56 | 37 | 44 | |
| Total Expenditure | -49 | -46 | -47 | -47 | -48 | -48 | -51 | -50 | -32 | -40 | |
| PBIDT | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | |
| Interest | -2 | -1 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | |
| Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | |
| Exceptional Items | |||||||||||
| PAT | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |
| Adjusted EPS | 4 | 5 | 5 | 4 | 5 | 4 | 6 | 4 | 3 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 0 | 0 | -2 | 2 | 2 | 2 | 2 | 5 | ||
| Cash Fr. Inv. | -1 | 0 | 0 | 0 | -2 | -1 | -1 | -1 | -1 | 0 | |
| Cash Fr. Finan. | 2 | -1 | 1 | 1 | 2 | -1 | -1 | 0 | -1 | -5 | |
| Net Change | 2 | -2 | 1 | -1 | 0 | 0 | -1 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 3 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
|
Sat, 13 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication In Compliances with Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the Newspaper Advertisement of the Standalone Un-Audited Financial Results of the Company for quarter ended June 30 2022 published in all the editions of The Free Press Journal and in Mumbai Edition of Navshakti (Regional Newspaper) on August 13 2022. |
|
Fri, 12 Aug 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 12 2022 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015. With reference to the above captioned subject we wish to inform you that the Board of Directors of the Company at their meeting held on Friday the August 12 2022 approved the following:? Standalone Un-Audited Financial Results for the quarter ended June 30 2022 as per Regulation 33 of SEBI (LODR) Regulations 2015.The said meeting commenced at 04:30 p.m. and concluded at 04:45 p.m. Kindly take the same on your record. |
|
Fri, 12 Aug 2022
Standalone Un-Audited Financial Results For The Quarter Ended June 30 2022 In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit following documents:1). Standalone Un-Audited Financial Results for the quarter ended June 30 2022.2). Limited Review Report for the quarter ended June 30 2022. |
| Fri, 12 Aug 2022 |
High Delivery Percentage
|
Opening at High
|
Closing Below Previous Low
|
High Decrease 6 Months
|
Close Crossing 50 SMA From Above
|
Equities
M.F.
Sectors